BioCatalyst

LXEO — Lexeo Therapeutics, Inc. catalysts

1 verified catalyst event(s) for Lexeo Therapeutics, Inc. (ticker LXEO). Each is linked to its official source. Verified as of 2026-08-06.

Next verified catalyst

2026-12-01 — Gene Therapy for ACM Due to a PKP2 Pathogenic Variant · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 4mo
ESTIMATED
 READOUT
Gene Therapy for ACM Due to a PKP2 Pathogenic Variant
Phase 1/2 · Arrhythmogenic Cardiomyopathy, PKP2-ACM
 LXEO Lexeo Therapeutics, Inc. LX2020 ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.